Clinical Trials
4 trialsNCT07419295 2026-05-22
TroFuse-031
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT03661320 2026-04-15
A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
Bristol-Myers Squibb
Phase 3 Active not recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT01094496 2020-02-13
A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)
Celldex Therapeutics
Phase 2 Terminated